Hey Folks,
Here are some key reasons to look into Co-Diagnostics, Inc. (CODX):
1. Gold Standard Accuracy at Rapid Test Prices — The Co-Dx PCR Pro delivers real-time PCR accuracy at roughly $20 per test, comparable to antigen-level pricing like Abbott's BinaxNOW at $24.99, even though antigen is considered a lower technology tier.
2. Patented Technology in Every Test — Co-Primers technology reduces false signals and speeds up testing cycles, and it is utilized in all Co-Dx tests. The platform is protected by more than 20 U.S. and foreign patents, trade secrets, and copyrights.
3. Massive Cost Advantage Over Competitors — A hypothetical nationwide deployment across 8,700 pharmacy locations would cost roughly $4.4 million for the Co-Dx PCR Pro versus $34.8 million for Abbott's ID Now.
4. Global Expansion Already Underway — CoSara Diagnostics in India has 15 tests cleared by CDSCO, a completed oligo synthesis lab, and manufacturing facilities under construction. CoMira Diagnostics targets Saudi Arabia and 18 other MENA-region countries.
5. Four Distinct Product Lines — Co-Dx offers the Co-Dx PCR Platform for point-of-care use, the Co-Dx Box for laboratories, Logix Smart PCR Test Kits for open-source instruments, and Vector Smart Test Kits for mosquito abatement across 19 U.S. states.
6. Enormous U.S. Addressable Market — The company is looking to target physicians and urgent care (500 million visits per year), pharmacies (over 61,715 locations), skilled nursing facilities (over 15,000), and home use—where 88.9% of the U.S. population lives within 5 miles of a pharmacy.
Anyways...
That's all for now!
Until Next Time,
-ZT Team
Post a Comment
Post a Comment